Oncology

Oncology Times Broadcast News with the Audio Journal of Oncology – Insulin-Like Growth Factor Inhibition In Lung Cancer

April 6, 2009
Source: 10th European Congress Perspectives in Lung Cancer, Brussels March 6-7, 2009 and Journal of Clinical Oncology
Silvia Novello
Silvia Novello

Giorgio Scagliotti
Giorgio Scagliotti

Peter Goodwin interviews Silvia Novello, and Giorgio Scagliotti from the University of Turin about harnessing insulin-like growth factor receptor inhibition in a phase II study which has shown clinical activity of figitumumab at least as significant as inhibitors of other growth factors already being used in cancer.

Download this interview

Add podcast to iTunes

Similar Interviews

  • New Targets Bring Promise For Lung Cancer Therapy

    • Egbert Smit EGBERT SMIT, Free University of Amsterdam There are a number of promising

  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

    • Robert Pirker ROBERT PIRKER , Medical University of Vienna Phase III study results have

  • Oncology Times Broadcast News with the Audio Journal of Oncology

    • Robert Pirker Scientific Editors: George Canellos, Dana-Farber Cancer Institute, Boston Gordon McVie, European Institute of Oncology, Milan Pat Price, Christie

    Post a comment